Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT784 | Cell Line | MDA-MB-468 | Homo sapiens | GI | = | 69.62 | % | 10579838 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 92.88 | % | 12193010 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 11900 | nM | 16124780 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 141.83 | % | 22703109 |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI | = | 88.64 | % | 20620056 |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI | = | 76.82 | % | 20620056 |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI | = | 106.61 | % | 20185316 |
NPT2 | Others | Unspecified | GI | = | 104.55 | % | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | GI | = | 92.6 | % | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI | = | 74.9 | % | PubChem BioAssay data set |
NPT2 | Others | Unspecified | GI | = | 74.88 | % | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI | = | 75.2 | % | PubChem BioAssay data set |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI | = | 93.08 | % | PubChem BioAssay data set |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI | = | 109.33 | % | PubChem BioAssay data set |
NPT2 | Others | Unspecified | GI | = | 83.22 | % | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | GI | = | 76.17 | % | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI | = | 68.34 | % | PubChem BioAssay data set |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI | = | 57.13 | % | DrugMatrix in vivo data: Pathology |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI | = | 35.46 | % | DrugMatrix in vivo data: Pathology |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI | = | 55.83 | % | DrugMatrix in vivo data: Pathology |
NPT6649 | Organism | Ceratitis capitata | Ceratitis capitata | Activity | = | 0 | % | 23691952 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 132.13 | % | PubChem BioAssay data set |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | > | 75 | % | PubChem BioAssay data set |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 72.71 | % | 10.6019/CHEMBL1201861 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 87.41 | % | 10.6019/CHEMBL1201861 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 9800 | nM | 18260638 |
NPT2 | Others | Unspecified | GI | = | 76.35 | % | 18680278 | |
NPT75 | Cell Line | U251 | Homo sapiens | GI | = | 85.11 | % | 16989516 |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI | = | 53.69 | % | 16989516 |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI | = | 43.17 | % | 16989516 |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI | = | 79.42 | % | 16989516 |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI | = | 83.44 | % | 25237727 |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI | = | 95.12 | % | 25237727 |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI | = | 67.73 | % | 25237727 |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI | = | 88.97 | % | 25237727 |
NPT6649 | Organism | Ceratitis capitata | Ceratitis capitata | Activity | = | 78.4 | % | 17850214 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 126.09 | % | 10.6019/CHEMBL1201861 |
NPT2 | Others | Unspecified | EC50 | = | 980 | nM | 21955940 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 11900 | nM | 21955940 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 8700 | nM | 7528786 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 121.4 | % | 19581457 |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI | = | 52.93 | % | 25016227 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 166.85 | % | 9358643 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 163.15 | % | 9358643 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 146.36 | % | 9358643 |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI | = | 86.88 | % | 19921834 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 9800 | nM | 17188868 |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI | = | 77 | % | 20961767 |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI | = | 65.21 | % | 19637893 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI | = | 85.49 | % | 20206533 |
NPT111 | Cell Line | K562 | Homo sapiens | GI | = | 66.1 | % | 20206533 |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI | = | 53.21 | % | 20131843 |
NPT385 | Cell Line | SR | Homo sapiens | GI | = | 45.98 | % | 20131843 |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI | = | 77.06 | % | 20131843 |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI | = | 91.33 | % | 20131843 |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI | = | 67.4 | % | 20206517 |
NPT2 | Others | Unspecified | GI | = | 78.73 | % | 20329733 | |
NPT32 | Organism | Mus musculus | Mus musculus | EC50 | = | 0.25 | mg/kg | 16252924 |
NPT2212 | Organism | Oncopeltus fasciatus | Oncopeltus fasciatus | Survival | = | 0 | % | 24084296 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 8700 | nM | 10843594 |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI | = | 93.29 | % | 25856683 |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI | = | 71 | % | 11858750 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI | = | 57.2 | % | 11858750 |
NPT386 | Cell Line | KM12 | Homo sapiens | GI | = | 71.48 | % | 12502327 |
NPT81 | Cell Line | A549 | Homo sapiens | GI | = | 73.7 | % | 19008110 |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI | = | 74.68 | % | 20472446 |
NPT387 | Cell Line | M14 | Homo sapiens | GI | = | 62.56 | % | 19459643 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 93.08 | % | DrugMatrix in vitro pharmacology data |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI | = | 98.57 | % | DrugMatrix in vitro pharmacology data |
NPT2 | Others | Unspecified | GI | = | 41.05 | % | DrugMatrix in vitro pharmacology data | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI | = | 39.28 | % | DrugMatrix in vitro pharmacology data |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI | = | 85.55 | % | DrugMatrix in vitro pharmacology data |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI | = | 97.51 | % | DrugMatrix in vitro pharmacology data |
NPT2 | Others | Unspecified | GI | = | 93.98 | % | DrugMatrix in vitro pharmacology data | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI | = | 98.16 | % | DrugMatrix in vitro pharmacology data |
NPT396 | Cell Line | T47D | Homo sapiens | GI | = | 73.91 | % | DrugMatrix in vitro pharmacology data |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI | = | 76.52 | % | DrugMatrix in vitro pharmacology data |
NPT368 | Cell Line | SN12C | Homo sapiens | GI | = | 73.32 | % | DrugMatrix in vitro pharmacology data |
NPT6649 | Organism | Ceratitis capitata | Ceratitis capitata | Activity | = | 100 | % | 18955520 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC473389 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9954 | High Similarity | NPC199259 |
0.9587 | High Similarity | NPC188239 |
0.9087 | High Similarity | NPC249342 |
0.8829 | High Similarity | NPC470873 |
0.8727 | High Similarity | NPC470874 |
0.7339 | Intermediate Similarity | NPC470843 |
0.7339 | Intermediate Similarity | NPC94541 |
0.7257 | Intermediate Similarity | NPC231342 |
0.7238 | Intermediate Similarity | NPC61813 |
0.7113 | Intermediate Similarity | NPC96131 |
0.7112 | Intermediate Similarity | NPC477135 |
0.7073 | Intermediate Similarity | NPC471634 |
0.7073 | Intermediate Similarity | NPC473806 |
0.7064 | Intermediate Similarity | NPC61637 |
0.7029 | Intermediate Similarity | NPC160527 |
0.7029 | Intermediate Similarity | NPC473650 |
0.6983 | Remote Similarity | NPC475476 |
0.6983 | Remote Similarity | NPC242446 |
0.6976 | Remote Similarity | NPC282033 |
0.6958 | Remote Similarity | NPC471284 |
0.6951 | Remote Similarity | NPC475424 |
0.6951 | Remote Similarity | NPC79107 |
0.6947 | Remote Similarity | NPC119700 |
0.6946 | Remote Similarity | NPC235900 |
0.694 | Remote Similarity | NPC32200 |
0.6916 | Remote Similarity | NPC34271 |
0.6904 | Remote Similarity | NPC250129 |
0.6862 | Remote Similarity | NPC475165 |
0.6835 | Remote Similarity | NPC187456 |
0.6818 | Remote Similarity | NPC97388 |
0.6814 | Remote Similarity | NPC165201 |
0.681 | Remote Similarity | NPC205403 |
0.6777 | Remote Similarity | NPC473547 |
0.6766 | Remote Similarity | NPC475151 |
0.6726 | Remote Similarity | NPC302191 |
0.6723 | Remote Similarity | NPC476175 |
0.6681 | Remote Similarity | NPC473747 |
0.6681 | Remote Similarity | NPC198339 |
0.668 | Remote Similarity | NPC473565 |
0.668 | Remote Similarity | NPC112547 |
0.6627 | Remote Similarity | NPC41318 |
0.6627 | Remote Similarity | NPC469312 |
0.6626 | Remote Similarity | NPC204303 |
0.6625 | Remote Similarity | NPC18661 |
0.6587 | Remote Similarity | NPC183426 |
0.6569 | Remote Similarity | NPC123019 |
0.6559 | Remote Similarity | NPC314552 |
0.6491 | Remote Similarity | NPC6093 |
0.6489 | Remote Similarity | NPC472842 |
0.6475 | Remote Similarity | NPC284102 |
0.6473 | Remote Similarity | NPC154293 |
0.646 | Remote Similarity | NPC97525 |
0.6458 | Remote Similarity | NPC1203 |
0.6445 | Remote Similarity | NPC477531 |
0.6431 | Remote Similarity | NPC252251 |
0.6422 | Remote Similarity | NPC476319 |
0.642 | Remote Similarity | NPC476106 |
0.6407 | Remote Similarity | NPC472444 |
0.6407 | Remote Similarity | NPC19679 |
0.6406 | Remote Similarity | NPC209174 |
0.6383 | Remote Similarity | NPC206967 |
0.6381 | Remote Similarity | NPC131273 |
0.6381 | Remote Similarity | NPC473441 |
0.6331 | Remote Similarity | NPC48353 |
0.6328 | Remote Similarity | NPC57690 |
0.6327 | Remote Similarity | NPC193777 |
0.6324 | Remote Similarity | NPC477532 |
0.6312 | Remote Similarity | NPC37473 |
0.6308 | Remote Similarity | NPC277351 |
0.6298 | Remote Similarity | NPC278540 |
0.6293 | Remote Similarity | NPC192270 |
0.6277 | Remote Similarity | NPC472443 |
0.6277 | Remote Similarity | NPC270009 |
0.6274 | Remote Similarity | NPC471583 |
0.6274 | Remote Similarity | NPC471782 |
0.6271 | Remote Similarity | NPC46413 |
0.6265 | Remote Similarity | NPC476492 |
0.6255 | Remote Similarity | NPC267423 |
0.6255 | Remote Similarity | NPC476044 |
0.6255 | Remote Similarity | NPC107836 |
0.625 | Remote Similarity | NPC141428 |
0.6241 | Remote Similarity | NPC284141 |
0.6241 | Remote Similarity | NPC311451 |
0.624 | Remote Similarity | NPC475602 |
0.624 | Remote Similarity | NPC478074 |
0.623 | Remote Similarity | NPC249428 |
0.6224 | Remote Similarity | NPC153042 |
0.6213 | Remote Similarity | NPC473189 |
0.6211 | Remote Similarity | NPC473667 |
0.621 | Remote Similarity | NPC201697 |
0.6208 | Remote Similarity | NPC181502 |
0.6208 | Remote Similarity | NPC85066 |
0.6203 | Remote Similarity | NPC246700 |
0.6198 | Remote Similarity | NPC177056 |
0.6192 | Remote Similarity | NPC290529 |
0.619 | Remote Similarity | NPC204491 |
0.6187 | Remote Similarity | NPC98371 |
0.6187 | Remote Similarity | NPC475498 |
0.6187 | Remote Similarity | NPC313884 |
0.6187 | Remote Similarity | NPC475137 |
0.6187 | Remote Similarity | NPC473850 |
0.6185 | Remote Similarity | NPC234999 |
0.6181 | Remote Similarity | NPC216428 |
0.6178 | Remote Similarity | NPC471190 |
0.6178 | Remote Similarity | NPC471977 |
0.6178 | Remote Similarity | NPC475362 |
0.6178 | Remote Similarity | NPC475644 |
0.6178 | Remote Similarity | NPC470486 |
0.6176 | Remote Similarity | NPC106833 |
0.6176 | Remote Similarity | NPC469497 |
0.6171 | Remote Similarity | NPC471564 |
0.6169 | Remote Similarity | NPC30456 |
0.6167 | Remote Similarity | NPC79293 |
0.6167 | Remote Similarity | NPC279401 |
0.6164 | Remote Similarity | NPC293472 |
0.6163 | Remote Similarity | NPC200888 |
0.6163 | Remote Similarity | NPC475085 |
0.6163 | Remote Similarity | NPC291535 |
0.6163 | Remote Similarity | NPC267926 |
0.6163 | Remote Similarity | NPC475112 |
0.6157 | Remote Similarity | NPC243834 |
0.6157 | Remote Similarity | NPC70956 |
0.6148 | Remote Similarity | NPC250807 |
0.6148 | Remote Similarity | NPC266192 |
0.6148 | Remote Similarity | NPC76565 |
0.6148 | Remote Similarity | NPC57797 |
0.6147 | Remote Similarity | NPC472586 |
0.6145 | Remote Similarity | NPC70155 |
0.6145 | Remote Similarity | NPC237702 |
0.6145 | Remote Similarity | NPC473182 |
0.6142 | Remote Similarity | NPC469594 |
0.6142 | Remote Similarity | NPC62367 |
0.6139 | Remote Similarity | NPC146824 |
0.6139 | Remote Similarity | NPC328186 |
0.6139 | Remote Similarity | NPC110151 |
0.6139 | Remote Similarity | NPC122968 |
0.6139 | Remote Similarity | NPC477787 |
0.6139 | Remote Similarity | NPC476110 |
0.6139 | Remote Similarity | NPC475600 |
0.6139 | Remote Similarity | NPC228377 |
0.6139 | Remote Similarity | NPC475631 |
0.6139 | Remote Similarity | NPC87152 |
0.6135 | Remote Similarity | NPC475778 |
0.6135 | Remote Similarity | NPC472553 |
0.6134 | Remote Similarity | NPC128751 |
0.6131 | Remote Similarity | NPC476514 |
0.613 | Remote Similarity | NPC473689 |
0.613 | Remote Similarity | NPC475303 |
0.613 | Remote Similarity | NPC475596 |
0.613 | Remote Similarity | NPC316841 |
0.613 | Remote Similarity | NPC292416 |
0.6128 | Remote Similarity | NPC217554 |
0.6126 | Remote Similarity | NPC30570 |
0.6126 | Remote Similarity | NPC477907 |
0.6126 | Remote Similarity | NPC477909 |
0.6126 | Remote Similarity | NPC42678 |
0.6124 | Remote Similarity | NPC235885 |
0.6122 | Remote Similarity | NPC475406 |
0.612 | Remote Similarity | NPC475422 |
0.6113 | Remote Similarity | NPC11408 |
0.6109 | Remote Similarity | NPC106593 |
0.6109 | Remote Similarity | NPC122463 |
0.6109 | Remote Similarity | NPC95783 |
0.6107 | Remote Similarity | NPC244839 |
0.6107 | Remote Similarity | NPC319880 |
0.6107 | Remote Similarity | NPC320324 |
0.6104 | Remote Similarity | NPC34508 |
0.6103 | Remote Similarity | NPC476493 |
0.6102 | Remote Similarity | NPC162812 |
0.61 | Remote Similarity | NPC473506 |
0.61 | Remote Similarity | NPC202503 |
0.6098 | Remote Similarity | NPC38959 |
0.6098 | Remote Similarity | NPC327904 |
0.6092 | Remote Similarity | NPC472844 |
0.6087 | Remote Similarity | NPC89549 |
0.608 | Remote Similarity | NPC472550 |
0.608 | Remote Similarity | NPC304179 |
0.608 | Remote Similarity | NPC48042 |
0.6078 | Remote Similarity | NPC144779 |
0.6078 | Remote Similarity | NPC294579 |
0.6077 | Remote Similarity | NPC470126 |
0.6074 | Remote Similarity | NPC195314 |
0.6073 | Remote Similarity | NPC162484 |
0.6073 | Remote Similarity | NPC472843 |
0.6071 | Remote Similarity | NPC292517 |
0.6071 | Remote Similarity | NPC151976 |
0.607 | Remote Similarity | NPC477912 |
0.6067 | Remote Similarity | NPC475844 |
0.6066 | Remote Similarity | NPC72211 |
0.6063 | Remote Similarity | NPC203614 |
0.6063 | Remote Similarity | NPC477910 |
0.6062 | Remote Similarity | NPC477902 |
0.6061 | Remote Similarity | NPC170751 |
0.6061 | Remote Similarity | NPC327769 |
0.6059 | Remote Similarity | NPC472108 |
0.6059 | Remote Similarity | NPC139291 |
0.6055 | Remote Similarity | NPC472555 |
0.6055 | Remote Similarity | NPC223590 |
0.6054 | Remote Similarity | NPC253580 |
0.605 | Remote Similarity | NPC99428 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC473389 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.6616 | Remote Similarity | NPD6503 | Clinical (unspecified phase) |
0.6559 | Remote Similarity | NPD5164 | Discontinued |
0.6387 | Remote Similarity | NPD6773 | Clinical (unspecified phase) |
0.637 | Remote Similarity | NPD7169 | Suspended |
0.6333 | Remote Similarity | NPD8244 | Phase 2 |
0.6333 | Remote Similarity | NPD2727 | Phase 2 |
0.6286 | Remote Similarity | NPD4305 | Clinical (unspecified phase) |
0.6265 | Remote Similarity | NPD6977 | Clinical (unspecified phase) |
0.6265 | Remote Similarity | NPD6978 | Phase 2 |
0.6235 | Remote Similarity | NPD7221 | Approved |
0.6235 | Remote Similarity | NPD7219 | Approved |
0.6189 | Remote Similarity | NPD7934 | Discovery |
0.6189 | Remote Similarity | NPD7932 | Clinical (unspecified phase) |
0.6189 | Remote Similarity | NPD7933 | Approved |
0.6189 | Remote Similarity | NPD7931 | Approved |
0.6187 | Remote Similarity | NPD6976 | Clinical (unspecified phase) |
0.6181 | Remote Similarity | NPD6455 | Phase 3 |
0.6157 | Remote Similarity | NPD6717 | Clinical (unspecified phase) |
0.6157 | Remote Similarity | NPD5003 | Discontinued |
0.6151 | Remote Similarity | NPD5912 | Clinical (unspecified phase) |
0.6151 | Remote Similarity | NPD5913 | Phase 3 |
0.6096 | Remote Similarity | NPD5939 | Approved |
0.6096 | Remote Similarity | NPD5936 | Approved |
0.6079 | Remote Similarity | NPD972 | Clinical (unspecified phase) |
0.6074 | Remote Similarity | NPD3791 | Clinical (unspecified phase) |
0.6067 | Remote Similarity | NPD7576 | Discontinued |
0.6066 | Remote Similarity | NPD3230 | Clinical (unspecified phase) |
0.6063 | Remote Similarity | NPD7218 | Clinical (unspecified phase) |
0.605 | Remote Similarity | NPD8364 | Approved |
0.605 | Remote Similarity | NPD8363 | Approved |
0.6047 | Remote Similarity | NPD6736 | Discontinued |
0.6035 | Remote Similarity | NPD8428 | Approved |
0.6035 | Remote Similarity | NPD8427 | Approved |
0.6035 | Remote Similarity | NPD8429 | Approved |
0.6031 | Remote Similarity | NPD3280 | Approved |
0.6024 | Remote Similarity | NPD7073 | Clinical (unspecified phase) |
0.6023 | Remote Similarity | NPD6494 | Phase 2 |
0.6023 | Remote Similarity | NPD7558 | Phase 2 |
0.6017 | Remote Similarity | NPD1325 | Approved |
0.6017 | Remote Similarity | NPD7474 | Suspended |
0.6017 | Remote Similarity | NPD1326 | Approved |
0.6016 | Remote Similarity | NPD2125 | Clinical (unspecified phase) |
0.6008 | Remote Similarity | NPD2920 | Discontinued |
0.6007 | Remote Similarity | NPD8426 | Approved |
0.6007 | Remote Similarity | NPD8425 | Approved |
0.6007 | Remote Similarity | NPD8365 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD4350 | Approved |
0.6 | Remote Similarity | NPD4349 | Approved |
0.6 | Remote Similarity | NPD1503 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD6803 | Clinical (unspecified phase) |
0.5992 | Remote Similarity | NPD5596 | Phase 2 |
0.5991 | Remote Similarity | NPD1554 | Clinical (unspecified phase) |
0.5985 | Remote Similarity | NPD6995 | Phase 1 |
0.5984 | Remote Similarity | NPD1322 | Clinical (unspecified phase) |
0.5979 | Remote Similarity | NPD8465 | Approved |
0.5979 | Remote Similarity | NPD8467 | Approved |
0.5979 | Remote Similarity | NPD8466 | Approved |
0.5975 | Remote Similarity | NPD2564 | Approved |
0.5975 | Remote Similarity | NPD2565 | Phase 2 |
0.5968 | Remote Similarity | NPD4502 | Phase 2 |
0.5966 | Remote Similarity | NPD4112 | Clinical (unspecified phase) |
0.5966 | Remote Similarity | NPD7418 | Discontinued |
0.5962 | Remote Similarity | NPD7548 | Discontinued |
0.5961 | Remote Similarity | NPD5902 | Approved |
0.5961 | Remote Similarity | NPD5903 | Approved |
0.596 | Remote Similarity | NPD3003 | Approved |
0.5957 | Remote Similarity | NPD7772 | Phase 3 |
0.5953 | Remote Similarity | NPD8109 | Clinical (unspecified phase) |
0.595 | Remote Similarity | NPD4699 | Discontinued |
0.5935 | Remote Similarity | NPD7956 | Approved |
0.5935 | Remote Similarity | NPD7955 | Approved |
0.5935 | Remote Similarity | NPD7889 | Clinical (unspecified phase) |
0.5934 | Remote Similarity | NPD1534 | Approved |
0.5926 | Remote Similarity | NPD4875 | Phase 3 |
0.5926 | Remote Similarity | NPD4876 | Phase 3 |
0.5897 | Remote Similarity | NPD8459 | Approved |
0.5897 | Remote Similarity | NPD8460 | Approved |
0.5896 | Remote Similarity | NPD2715 | Clinical (unspecified phase) |
0.5896 | Remote Similarity | NPD3932 | Clinical (unspecified phase) |
0.5873 | Remote Similarity | NPD3930 | Clinical (unspecified phase) |
0.5873 | Remote Similarity | NPD6290 | Phase 2 |
0.5866 | Remote Similarity | NPD7673 | Phase 3 |
0.5861 | Remote Similarity | NPD8468 | Phase 2 |
0.5858 | Remote Similarity | NPD4454 | Phase 2 |
0.5857 | Remote Similarity | NPD7708 | Approved |
0.5857 | Remote Similarity | NPD2721 | Clinical (unspecified phase) |
0.5847 | Remote Similarity | NPD2177 | Approved |
0.5847 | Remote Similarity | NPD2175 | Phase 3 |
0.5847 | Remote Similarity | NPD2176 | Approved |
0.584 | Remote Similarity | NPD3928 | Approved |
0.584 | Remote Similarity | NPD5669 | Clinical (unspecified phase) |
0.584 | Remote Similarity | NPD3931 | Approved |
0.583 | Remote Similarity | NPD7803 | Approved |
0.583 | Remote Similarity | NPD1229 | Phase 2 |
0.5823 | Remote Similarity | NPD4600 | Approved |
0.5823 | Remote Similarity | NPD4601 | Approved |
0.5813 | Remote Similarity | NPD6491 | Clinical (unspecified phase) |
0.5806 | Remote Similarity | NPD7946 | Pre-registration |
0.5803 | Remote Similarity | NPD5807 | Phase 2 |
0.5798 | Remote Similarity | NPD2615 | Phase 3 |
0.5798 | Remote Similarity | NPD2616 | Phase 3 |
0.5795 | Remote Similarity | NPD6456 | Discontinued |
0.5792 | Remote Similarity | NPD7252 | Clinical (unspecified phase) |
0.5789 | Remote Similarity | NPD5411 | Discontinued |
0.5787 | Remote Similarity | NPD7672 | Approved |
0.5787 | Remote Similarity | NPD8423 | Phase 2 |
0.5787 | Remote Similarity | NPD5658 | Approved |
0.5787 | Remote Similarity | NPD7671 | Approved |
0.5787 | Remote Similarity | NPD8399 | Phase 1 |
0.5783 | Remote Similarity | NPD4118 | Clinical (unspecified phase) |
0.5783 | Remote Similarity | NPD1768 | Approved |
0.5782 | Remote Similarity | NPD8358 | Approved |
0.5781 | Remote Similarity | NPD6220 | Phase 3 |
0.5771 | Remote Similarity | NPD5530 | Phase 1 |
0.5769 | Remote Similarity | NPD6985 | Discontinued |
0.5768 | Remote Similarity | NPD7688 | Phase 1 |
0.5766 | Remote Similarity | NPD7921 | Approved |
0.5761 | Remote Similarity | NPD4951 | Discontinued |
0.5756 | Remote Similarity | NPD6641 | Approved |
0.5756 | Remote Similarity | NPD6642 | Approved |
0.5753 | Remote Similarity | NPD5612 | Discontinued |
0.5751 | Remote Similarity | NPD5744 | Clinical (unspecified phase) |
0.5747 | Remote Similarity | NPD7194 | Discontinued |
0.5741 | Remote Similarity | NPD6160 | Clinical (unspecified phase) |
0.5737 | Remote Similarity | NPD4511 | Phase 1 |
0.5726 | Remote Similarity | NPD5522 | Clinical (unspecified phase) |
0.5725 | Remote Similarity | NPD7947 | Clinical (unspecified phase) |
0.572 | Remote Similarity | NPD8395 | Approved |
0.572 | Remote Similarity | NPD8396 | Approved |
0.5714 | Remote Similarity | NPD4328 | Approved |
0.5714 | Remote Similarity | NPD5721 | Clinical (unspecified phase) |
0.5714 | Remote Similarity | NPD6281 | Approved |
0.5714 | Remote Similarity | NPD2381 | Approved |
0.5714 | Remote Similarity | NPD2382 | Approved |
0.5714 | Remote Similarity | NPD2380 | Approved |
0.5709 | Remote Similarity | NPD4901 | Clinical (unspecified phase) |
0.5703 | Remote Similarity | NPD5834 | Phase 3 |
0.5703 | Remote Similarity | NPD4506 | Discontinued |
0.5703 | Remote Similarity | NPD5835 | Phase 3 |
0.5702 | Remote Similarity | NPD5083 | Clinical (unspecified phase) |
0.5698 | Remote Similarity | NPD6657 | Clinical (unspecified phase) |
0.5697 | Remote Similarity | NPD5497 | Clinical (unspecified phase) |
0.5692 | Remote Similarity | NPD8160 | Phase 2 |
0.5691 | Remote Similarity | NPD6630 | Clinical (unspecified phase) |
0.5683 | Remote Similarity | NPD7769 | Phase 3 |
0.5681 | Remote Similarity | NPD648 | Clinical (unspecified phase) |
0.5681 | Remote Similarity | NPD8489 | Phase 1 |
0.5676 | Remote Similarity | NPD7571 | Clinical (unspecified phase) |
0.5667 | Remote Similarity | NPD3920 | Phase 2 |
0.5666 | Remote Similarity | NPD7181 | Phase 3 |
0.5665 | Remote Similarity | NPD5930 | Phase 3 |
0.5658 | Remote Similarity | NPD8442 | Discontinued |
0.5654 | Remote Similarity | NPD7707 | Approved |
0.5647 | Remote Similarity | NPD7957 | Phase 1 |
0.5647 | Remote Similarity | NPD7958 | Clinical (unspecified phase) |
0.5641 | Remote Similarity | NPD5140 | Approved |
0.5641 | Remote Similarity | NPD5138 | Approved |
0.5636 | Remote Similarity | NPD2844 | Phase 3 |
0.5636 | Remote Similarity | NPD7770 | Phase 3 |
0.5633 | Remote Similarity | NPD8431 | Approved |
0.5627 | Remote Similarity | NPD3258 | Approved |
0.5625 | Remote Similarity | NPD7222 | Phase 2 |
0.5625 | Remote Similarity | NPD1392 | Approved |
0.5623 | Remote Similarity | NPD1856 | Discontinued |
0.5622 | Remote Similarity | NPD4771 | Phase 2 |
0.562 | Remote Similarity | NPD8017 | Clinical (unspecified phase) |
0.562 | Remote Similarity | NPD8321 | Discontinued |
0.562 | Remote Similarity | NPD8016 | Phase 3 |
0.5618 | Remote Similarity | NPD53 | Approved |
0.5618 | Remote Similarity | NPD7778 | Approved |
0.5618 | Remote Similarity | NPD7777 | Approved |
0.5603 | Remote Similarity | NPD2739 | Clinical (unspecified phase) |
0.5602 | Remote Similarity | NPD4079 | Approved |
0.5602 | Remote Similarity | NPD8386 | Phase 2 |
0.5602 | Remote Similarity | NPD4076 | Approved |
PubChem CID   | 44450809 |
ChEMBL   | CHEMBL405864 |
ZINC   |
Molecular Weight:   | 633.29 |
ALogP:   | 0.1556 |
MLogP:   | 4.65 |
XLogP:   | 2.025 |
# Rotatable Bonds:   | 10 |
Polar Surface Area:   | 103.71 |
# H-Bond Aceptor:   | 7 |
# H-Bond Donor:   | 4 |
# Rings:   | 10 |
# Heavy Atoms:   | 45 |